Jason A. Keyes - Feb 14, 2025 Form 4 Insider Report for Equillium, Inc. (EQ)

Role
Chief Financial Officer
Signature
/s/ Jason A. Keyes
Stock symbol
EQ
Transactions as of
Feb 14, 2025
Transactions value $
$0
Form type
4
Date filed
2/19/2025, 07:33 PM
Previous filing
Jan 24, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EQ Employee Stock Option (right to buy) Award +70K 70K Feb 14, 2025 Common Stock 70K $0.79 Direct F1, F2
transaction EQ Employee Stock Option (right to buy) Disposed to Issuer -70K -100% 0 Feb 14, 2025 Common Stock 70K $2.45 Direct F1, F2
transaction EQ Employee Stock Option (right to buy) Award +90K 90K Feb 14, 2025 Common Stock 90K $0.79 Direct F1, F2
transaction EQ Employee Stock Option (right to buy) Disposed to Issuer -90K -100% 0 Feb 14, 2025 Common Stock 90K $2.45 Direct F1, F2
transaction EQ Employee Stock Option (right to buy) Award +100K 100K Feb 14, 2025 Common Stock 100K $0.79 Direct F1, F2
transaction EQ Employee Stock Option (right to buy) Disposed to Issuer -100K -100% 0 Feb 14, 2025 Common Stock 100K $5.03 Direct F1, F2
transaction EQ Employee Stock Option (right to buy) Award +125K 125K Feb 14, 2025 Common Stock 125K $0.79 Direct F1, F2
transaction EQ Employee Stock Option (right to buy) Disposed to Issuer -125K -100% 0 Feb 14, 2025 Common Stock 125K $3.86 Direct F1, F2
transaction EQ Employee Stock Option (right to buy) Award +175K 175K Feb 14, 2025 Common Stock 175K $0.79 Direct F1, F2
transaction EQ Employee Stock Option (right to buy) Disposed to Issuer -175K -100% 0 Feb 14, 2025 Common Stock 175K $1.06 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.
F2 On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged.